Test Your Knowledge: ASCO 2020 Quiz It’s no question that advancements in lung cancer treatment were in the spotlight at ASCO...
Phase III ADAURA Trial: Practice Changing Results for NSCLC Adjuvant osimertinib demonstrated a statistically significant and clinically meaningful benefit...